Name: UMIN ID:
Unique ID issued by UMIN | UMIN000038459 |
---|---|
Receipt number | R000043558 |
Scientific Title | To evaluate the efficacy and safety of sitagliptin for the long-term treatment of type 2 diabetes |
Date of disclosure of the study information | 2019/11/01 |
Last modified on | 2021/11/06 00:17:48 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2019/11/01 09:06:24 | ||
2 | Update | 2019/11/01 20:51:32 | Number of participants that the trial has enrolled |
|
3 | Update | 2020/05/01 11:41:08 | Email1 |
|
4 | Update | 2020/05/02 10:04:30 | Last follow-up date |
|
5 | Update | 2020/11/01 10:23:58 | Last follow-up date |
|
6 | Update | 2021/05/02 15:33:10 | Last follow-up date |
|
7 | Update | 2021/08/27 10:52:14 | ||
8 | Update | 2021/11/01 23:24:14 | Date of closure to data entry |
|
9 | Update | 2021/11/05 15:27:57 | Results Date of the first journal publication of results Adverse events Adverse events |
|
10 | Update | 2021/11/05 16:00:46 | Adverse events Outcome measures |
|
11 | Update | 2021/11/05 16:16:56 | Baseline Characteristics |
|
12 | Update | 2021/11/05 17:08:06 | Baseline Characteristics Participant flow Participant flow |
|
13 | Update | 2021/11/05 17:20:36 | Participant flow |
|
14 | Update | 2021/11/05 22:04:15 | Recruitment status |
|
15 | Update | 2021/11/05 23:50:16 | URL releasing protocol Publication of results URL related to results and publications Results Results date posted Baseline Characteristics Participant flow Outcome measures |
|
16 | Update | 2021/11/06 00:17:48 | Date of the first journal publication of results Participant flow |